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Several studies involving immunohistochemical methods to assess external auditory canal epidermis 
have been performed with different objectives. With this method it is possible to assess the expression 
of various antigens such as cytokeratins, cytokines, and hyperproliferation markers among others. 
Aim: to revise, describe and analyze the knowledge generated by identifiable papers published on 
the worldwide literature about immunohistochemical hyperproliferation markers in normal external 
auditory canal epidermis. 
Materials and Methods: systematic review of the papers published until 2009, in indexed 
international journals. 
Results: Various antigens related to hyperproliferation were investigated by immunohistochemical 
methods among the included papers. The most studied ones were cytokeratin 16, Ki-67 and PCNA. 
Conclusions: most of the studies utilized external auditory canal epidermis as control sample to 
study external ear or middle ear cholesteatoma with immunohistochemical methods. There is a 
hyperproliferative antigen concentration, such as CK16, Ki-67 and PCNA, in the annulus tympanicus, 
adjacent meatus and tympanic regions, mainly in the lower areas.
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INTRODUCTION
Numerous studies involving immunohistochemical 
methods used to assess the epidermis of the external 
auditory canal (EAC) have already been carried out with 
the most varied objectives. By means of immunohistoche-
mistry, initially used to diagnose tumors, it is also possible 
to study the mechanisms of skin migration in the external 
auditory canal, local immune response, the expression 
patterns of intermediate filaments, the presence of cytoki-
nes and other antigens, as well as the evaluation of new 
treatment proposals for the diseases that affect the canal1-3.
A deep knowledge of the immunohistochemical 
patterns of the external auditory canal epidermis directly 
associated with hyperproliferation helps understand the 
genesis of the many diseases which affect it (EAC cho-
lesteatoma, benign necrotizing external otitis; epidermal 
packing), besides contributing to the choice of the best 
treatment and to establish the prognosis for each disease3.
One of the most widely accepted theories to explain 
the genesis of the middle ear acquired cholesteatoma is the 
external auditory canal epidermis migration to inside the 
tympanic cavity by means of a perforation on the tympa-
nic membrane or by suction of its pars flacida2. However, 
there still are some controversial issues:
- Why do we have this abnormal migration in some 
cases when, physiologically, the local migration has a cen-
tripetal direction on the tympanic membrane and lateral 
on the external auditory canal?
- Why does it happen only in certain persons?
- What makes cholesteatomas more or less aggres-
sive?
These doubts motivated the need to study the 
hyperproliferative characteristics of the external auditory 
meatus epidermis by means of immunohistochemical tech-
niques, in the attempt to understand this peculiar behavior.
The goal of the present study was to revise, describe 
and analyze the expression of hyperproliferation immu-
nohistochemical markers on the epidermis of the normal 
external auditory canal.
MATERIALS AND METHODS
In order to analyze the studies involving the immu-
nohistochemical pattern of the external auditory meatus 
epidermis we did a systematic review of all the identifiable 
papers published until the year of 2009 in internationally 
indexed journals about: 
- Immunohistochemical methods used to study EAM 
epithelial samples.
- Immunohistochemical patterns of the normal EAC 
epidermis.
- Employment of these methods to the different 
diseases which affect the EAC.
In order to collect the studies we used the follo-
wing electronic databases: PubMed (MEDLINE), Cochrane 
Collaboration Systematic Reviews (CCTR), Latin-American 
and Caribbean Health Literature (LILACS) and Scientific 
Electronic Library Online (SciELO).
For the precise choice of key-words, we analyzed 
the remission indexes of two periods indexed on MEDLINE 
with an impact factor greater than 1.0, which had papers 
associated with the topic in this study. They were: The 
Laryngoscope (impact factor in 2005: 1.617), with the 
paper from Vennix et al. [1]1 and the International Journal 
of Molecular Medicine (impact factor in 2005: 2.090), 
with the paper from Naim et al [1]2. After analyzing these 
papers, we chose the key-words: immunohistochemistry 
(IMH) and external auditory canal (EAC). We also assessed 
the bibliographic references of the papers selected, for 
the inclusion of studies which were not identified by the 
investigation with the chosen key-words.
The inclusion criteria were:
• Papers published in indexed journals identifiable 
in the world literature
• Papers directly associated to the study of immu-
nohistochemical markers of a normal external auditory 
canal epidermis hyperproliferation
The exclusion criteria were:
• Identified papers without direct or indirect asso-
ciation with the immunohistochemical evaluation of the 
normal external acoustic meatus epidermis.
• Papers on the uncommon disorders of the ex-
ternal auditory meatus and without  associations with the 
epithelium.
• Papers which antigens used did not have direct 
association with the epithelial tissue or with the choles-
teatoma.
RESULTS
The search on the electronic databases with the 
combination of the key-words chosen yielded 91 papers 
(Chart 1).
After analyzing the selected papers, 75 were ruled 
out for not having direct associations with the goals of this 
study. With that, we only included 16 papers in this study.
As to study designs, 14 (87.5%) were cross-sectio-
nal1-14 and only two (12.5%) were experimental15, 16.
Among all the papers included in this review, five 
(31.25%) were published with the only goal of analyzing, 
by means of immunohistochemistry, the epidermis of the 
normal external auditory meatus1,4,5,8,16. The other 11 stu-
dies (68.75%) were used only as control sample to assess 
the immunoexpression of cholesteatoma antigens, of the 
middle or external ear2,7,8,10-16.
Many markers were studied by means of the immu-
nohistochemical methods in the investigations analyzed. Of 
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studies done exclusively on the epidermis of the normal 
EAC as control, from a total of seven studies. The other 
most studied antigens were the Ki-67, in six papers and 
the PCNA, in three papers. (Charts 2 and 3).
DISCUSSION
Among the markers mentioned in this paper, the 
most studied ones were cytokeratins (CK), a complex of 20 
polypeptides of the family of intermediate filaments which 
make up the cytoskeleton of the epithelial cells. These 
filaments are divided according to their molecular weight 
and their isoelectric point, in two subfamilies: the basic and 
the acid ones. One acid CK and one basic CK form a pair 
of CKs. Each pair can determine the differentiation stage 
of the keratocytes, proliferative capacity, as well as the 
location and environmental growth conditions. According 
to Ribeiro et al. [1]3 CK16 is found in tissues under hyperpro-
liferation, such as in benign hyperproliferative epidermal 
diseases (common wart, psoriasis, actinic keratosis and 
seborrheic dermatitis) and in tissues under healing stages 
and in malignant epidermal diseases such as squamous 
cell carcinoma. It is absent in the normal epidermis, except 
in the zones submitted to pressure and friction (feet soles, 
finger and heel pads) and in hair follicles coating.
The cytokeratins, despite being the more frequently 
studied proliferation markers, were exclusively studied in 
the epidermis of normal EAC only by Broekaert, Boedts 
[1]4, Lepercque et al [1]5, Vennix et al.1 and Sanjuan et al.[1]6. 
Other authors studied it in diseases of the middle and 
external ears, using the canal epidermis only as control. 
Broekaert, Boedts4, Lepercque et al.5, Vennix et al.1 studied 
the distribution of cytokeratins in the different parts of the 
EAC and in the outer portion of the tympanic membrane, 
also indicating in which epithelium layer the CK were 
expressed. They observed that CK16 in the most medial 
and inferior portion of the bony canal, in the keratocytes 
of the suprabasal layers. This CK was not expressed in the 
cartilaginous portion of the canal. According to Vennix et 
al.1, CK 16 was present in the fibrous-cartilaginous annu-
lus, in the pars flaccida of the tympanic membrane and 
in its pars tensa, near the handle of malleus. Lepercque 
et al.5 noticed a gradual reduction on the intensity of the 
CK 16 in a centripetal direction on the membrane. This 
shows a proliferative capacity of the suprabasal layers of 
the fibrous-cartilaginous annulus. Sanjuan et al.16 studied 
the expression of cytokeratins 5, 10, 16, 17 and 19 on the 
epidermis of the normal EAC and in cells of the epidermal 
EAC from culture. The authors observed that the patterns of 
expression of these filaments were maintained before and 
after the culture, including the location of the epidermal 
layers seen by Lepercque et al.5 and Vennix et al.1.
In the studies which analyzed the EAC epithelium 
only as control, there was CK 16 expression in the same 
EAC region, in the suprabasal layers; nonetheless, the au-
Chart 1. Papers found after searching the electronic databases
 IMH EAC IMH + EAC
PubMed (Medline) 405.268 4148 91
CCTR 808 37 0
LILACS 945 73 0
SciELO 290 15 0
PubMed: database for Medline search; Medline: Medical Literature 
Analysis and Retrieval System Online; CCTR: Cochrane Collaboration 
Systematic Reviews; LILACS: Latin American and Caribbean Literature 
in Health Sciences of International Literature of the Americas and the 
Caribbean; SciELO: Scientific Electronic Library Online; IMH: immu-
nohistochemistry; EAC: external auditory canal.
Chart 2. Antigens tested exclusively on the normal external auditory 
meatus epidermis.
Year Author # of samples Antigens tested
1993
Broekaert, 
Boedts
Not specified
CK 4, 5, 7, 8, 10, 13, 
14, 16, 18 e 19
1993
Lepercque 
et al.
6
CK 4, 5, 7, 8, 10, 13, 
14, 16, 18 e 19
1996 Vennix et al. 8
CK 5, 6, 7, 8, 10, 13, 
14, 16, 17, 18 e 19
1997 Kakoi et al. 8 Ki-67 e PCNA
2007 Sanjuan et al. 10 CK 5, 10, 16, 17 e 19
Chart 3. Antigens tested on the epidermis of the external auditory 
canal associated with cholesteatoma
Year Author
# of 
samples
Antigens tested
1992 Broekaert et al. 5
CK 4, 5, 7, 8, 10, 13, 
14, 16, 18 e 19
1994 Sasaki, Huang 2 CK 13 e 16
1996 Schilling et al. 13 Ki-67 
1998 Kojima et al. 10 PCNA
1998 Tanaka et al. 5 PCNA 
1999 Kim, Chung 26
CK 4, 8, 10, 13, 16, 
17, 18 e 19
2001 Bayazít et al. 18 P27
2003 Adamkzyc et al. 15 Ki-67
2004 Ribeiro et al. 1 CK 16 e Ki-67
2005 Raynov et al. 5 Ki-67
2006 Hwang et al. 10 Ki-67 e PPAR-gama
the five papers investigating exclusively the normal EAC 
epidermis, we analyzed the expression of Ki-67, vimentin 
PCNA, IgA, IgG, IgM and many other cytokeratins1,4,5,8,16.
The cytokeratins were studied in four of the five 
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thors did not report on the place from which the samples 
were obtained6, except for Broekaert et al.7 who observed 
CK 16 presence on the fibrocartilaginous annulus, as well 
as on the juxta-tympanic epithelium (Figure 1).
in the EAC epidermis PCNA, and the former observed its 
expression on the basal layer, extending to the suprabasal 
layers of the canal epidermis, and the latter only on the 
basal layer. Since in none of these papers there was a 
specific location of where the samples were taken from, 
it is not possible to state that only the region near the 
annulus is positive for PCNA.
Some other antigens associated with hyperprolifera-
tion were found on the epidermis of the external auditory 
canal; however, it was only in one paper and without a 
description of the place where the samples were taken 
from12,15. They may corroborate even further the hyperpro-
liferative status of the epidermis in this region. It is the case 
of p27, studied by Bayazít et al.15 and of the PPAR-gama, 
by Hwang et al.12, which expressions were seen on the 
epidermis of the normal external auditory canal epidermis.
As shown by the papers hereby described, the epi-
dermis of the external auditory canal has the expression of 
proliferation markers, but more specifically in its deepest 
part, next to the fibrocartilaginous annulus. It is in this 
region where we find the epithelial migration which will 
originate the middle ear cholesteatoma, according to a 
theory very much accepted for its genesis.2 There still is 
no clinical application for the routine test of these markers 
as a prognostic factor in patients with chronic otitis media. 
Nonetheless, with the progression of the studies and a gre-
ater understanding of the hyperproliferative characteristics 
of the EAC, many doubts will be increasingly near expla-
nation such as, for example, the risk of developing middle 
ear cholesteatoma in patients with tympanic perforation, 
evaluation of the cholesteatoma aggressiveness or even 
the risk estimation of recurrence after surgical treatment.
Figure 1. CK 16 expression on the suprabasal layers of the normal 
external auditory meatus (source: Morphology Department - Medical 
Sciences School - Santa Casa de São Paulo).
Another very much studied marker of hyperproli-
feration was the Ki-67nuclear antigen, which is a marker 
associated with cell proliferation and was studied in five 
papers8-12. All the authors found expressions of this marker 
in the normal external auditory canal; however, only one 
of the papers discusses where the samples were obtained 
from. Kakoi et al.8 observed the presence of Ki-67 on the 
basal cells of the pars flaccida and the pars tensa of the 
tympanic membrane, in the fibrocartilaginous annulus 
and in the region near the handle of the malleus. On the 
canal epidermis, Ki-67 was seen, especially near the infe-
rior annular region. Both in the EAC and in the tympanic 
membrane, the expression of this maker coincides with 
that from cytokeratin 16, showing the hyperproliferative 
characteristic of these regions. Schilling et al.9, Adamczyk 
et al.10, Raynov et al.11 and Hwang et al. [1]12 observed a 
strong positiveness for Ki-67 on the EAC epidermis, without 
however specifying the location of where the samples 
were obtained from (Figure 2).
Another nuclear antigen of cell proliferation, PCNA, 
was studied in the normal EAC in three papers8,13,14. Kakoi 
et al.8, who studied this antigen together with Ki-67, found 
a similar pattern of expression on the basal layers of the 
regions near the fibrocartilaginous annulus, including 
the bony portion of the canal. They showed that there 
is a gradual reduction of its expression on the tympanic 
membrane in a centripetal direction, similar to the CK16. 
Kojima et al.13 and Tanaka et al.14 also found positiveness 
Figure 2. Ki-67 expression on the basal layer, extending to the su-
prabasal layers of the normal external auditory meatus (source: Ki-67 
expression on the basal layer, extending to the suprabasal layers of 
the normal external auditory canal epithelium (source: Morphology 
Department - Medical Sciences School - Santa Casa de São Paulo).
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CONCLUSION
1. There is a concentration of hyperproliferation 
markers on the fibrocartilaginous annulus and on the 
adjacent external acoustic canal and tympanic membrane, 
especially on the lowest portions of the EAC;
2. CK16 if found on the normal external auditory 
canal in its bony portion and, on the tympanic membrane 
its expression reduces in the centripetal direction;
3. Ki-67 and the PCNA are also found on the bony 
portion of the external auditory canal and on the tympa-
nic membrane, in the same places where we find CK 16 
expression.
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